nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilazapril—ABCB1—Mitomycin—urinary bladder cancer	0.231	0.506	CbGbCtD
Cilazapril—ABCB1—Gemcitabine—urinary bladder cancer	0.0666	0.146	CbGbCtD
Cilazapril—ABCB1—Cisplatin—urinary bladder cancer	0.0484	0.106	CbGbCtD
Cilazapril—ABCB1—Etoposide—urinary bladder cancer	0.0476	0.104	CbGbCtD
Cilazapril—ABCB1—Doxorubicin—urinary bladder cancer	0.0324	0.0708	CbGbCtD
Cilazapril—ABCB1—Methotrexate—urinary bladder cancer	0.0314	0.0686	CbGbCtD
Cilazapril—ACE—umbilical vein—urinary bladder cancer	0.0204	0.171	CbGeAlD
Cilazapril—ACE—urine—urinary bladder cancer	0.0165	0.138	CbGeAlD
Cilazapril—SLC15A1—epithelium—urinary bladder cancer	0.00607	0.0506	CbGeAlD
Cilazapril—Mitiglinide—UGT2B7—urinary bladder cancer	0.00599	0.506	CrCbGaD
Cilazapril—ACE—prostate gland—urinary bladder cancer	0.00592	0.0494	CbGeAlD
Cilazapril—SLC15A1—renal system—urinary bladder cancer	0.00563	0.047	CbGeAlD
Cilazapril—SLC15A2—prostate gland—urinary bladder cancer	0.00516	0.0431	CbGeAlD
Cilazapril—ACE—seminal vesicle—urinary bladder cancer	0.00501	0.0418	CbGeAlD
Cilazapril—SLC15A2—seminal vesicle—urinary bladder cancer	0.00437	0.0364	CbGeAlD
Cilazapril—ACE—epithelium—urinary bladder cancer	0.00435	0.0363	CbGeAlD
Cilazapril—ACE—smooth muscle tissue—urinary bladder cancer	0.00419	0.035	CbGeAlD
Cilazapril—SLC15A1—vagina—urinary bladder cancer	0.00408	0.034	CbGeAlD
Cilazapril—ACE—renal system—urinary bladder cancer	0.00404	0.0337	CbGeAlD
Cilazapril—ACE—urethra—urinary bladder cancer	0.00396	0.0331	CbGeAlD
Cilazapril—SLC15A2—renal system—urinary bladder cancer	0.00352	0.0294	CbGeAlD
Cilazapril—SLC15A2—urethra—urinary bladder cancer	0.00346	0.0288	CbGeAlD
Cilazapril—ACE—female reproductive system—urinary bladder cancer	0.00323	0.027	CbGeAlD
Cilazapril—SLC15A2—female reproductive system—urinary bladder cancer	0.00282	0.0235	CbGeAlD
Cilazapril—SLC15A2—vagina—urinary bladder cancer	0.00255	0.0213	CbGeAlD
Cilazapril—Mitiglinide—PPARG—urinary bladder cancer	0.00234	0.197	CrCbGaD
Cilazapril—Benazepril—MTHFR—urinary bladder cancer	0.00233	0.197	CrCbGaD
Cilazapril—ABCB1—prostate gland—urinary bladder cancer	0.00208	0.0174	CbGeAlD
Cilazapril—ACE—lymph node—urinary bladder cancer	0.00189	0.0158	CbGeAlD
Cilazapril—ABCB1—seminal vesicle—urinary bladder cancer	0.00176	0.0147	CbGeAlD
Cilazapril—SLC15A2—lymph node—urinary bladder cancer	0.00165	0.0138	CbGeAlD
Cilazapril—ABCB1—epithelium—urinary bladder cancer	0.00153	0.0128	CbGeAlD
Cilazapril—ABCB1—renal system—urinary bladder cancer	0.00142	0.0119	CbGeAlD
Cilazapril—ABCB1—urethra—urinary bladder cancer	0.0014	0.0116	CbGeAlD
Cilazapril—Nateglinide—PPARG—urinary bladder cancer	0.00119	0.101	CrCbGaD
Cilazapril—ABCB1—female reproductive system—urinary bladder cancer	0.00114	0.00949	CbGeAlD
Cilazapril—ABCB1—vagina—urinary bladder cancer	0.00103	0.00859	CbGeAlD
Cilazapril—ABCB1—lymph node—urinary bladder cancer	0.000665	0.00555	CbGeAlD
Cilazapril—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000358	0.000873	CcSEcCtD
Cilazapril—Pollakiuria—Doxorubicin—urinary bladder cancer	0.000356	0.000867	CcSEcCtD
Cilazapril—Asthenia—Gemcitabine—urinary bladder cancer	0.000355	0.000865	CcSEcCtD
Cilazapril—Pharyngitis—Methotrexate—urinary bladder cancer	0.000354	0.000861	CcSEcCtD
Cilazapril—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000352	0.000857	CcSEcCtD
Cilazapril—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000352	0.000857	CcSEcCtD
Cilazapril—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000351	0.000856	CcSEcCtD
Cilazapril—Epistaxis—Epirubicin—urinary bladder cancer	0.00035	0.000853	CcSEcCtD
Cilazapril—Pruritus—Gemcitabine—urinary bladder cancer	0.00035	0.000853	CcSEcCtD
Cilazapril—Nausea—Thiotepa—urinary bladder cancer	0.000349	0.000851	CcSEcCtD
Cilazapril—Urethral disorder—Methotrexate—urinary bladder cancer	0.000349	0.000851	CcSEcCtD
Cilazapril—Sinusitis—Epirubicin—urinary bladder cancer	0.000348	0.000849	CcSEcCtD
Cilazapril—Feeling abnormal—Etoposide—urinary bladder cancer	0.000348	0.000848	CcSEcCtD
Cilazapril—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000348	0.000847	CcSEcCtD
Cilazapril—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000347	0.000844	CcSEcCtD
Cilazapril—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000346	0.000842	CcSEcCtD
Cilazapril—Pruritus—Fluorouracil—urinary bladder cancer	0.000344	0.000839	CcSEcCtD
Cilazapril—Visual impairment—Methotrexate—urinary bladder cancer	0.000343	0.000836	CcSEcCtD
Cilazapril—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000341	0.00083	CcSEcCtD
Cilazapril—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00034	0.000828	CcSEcCtD
Cilazapril—Bradycardia—Epirubicin—urinary bladder cancer	0.000339	0.000827	CcSEcCtD
Cilazapril—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000339	0.000825	CcSEcCtD
Cilazapril—Renal failure—Doxorubicin—urinary bladder cancer	0.000338	0.000823	CcSEcCtD
Cilazapril—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000337	0.000821	CcSEcCtD
Cilazapril—Urticaria—Etoposide—urinary bladder cancer	0.000336	0.000818	CcSEcCtD
Cilazapril—Rhinitis—Epirubicin—urinary bladder cancer	0.000334	0.000814	CcSEcCtD
Cilazapril—Abdominal pain—Etoposide—urinary bladder cancer	0.000334	0.000814	CcSEcCtD
Cilazapril—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000334	0.000814	CcSEcCtD
Cilazapril—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000333	0.000811	CcSEcCtD
Cilazapril—Tinnitus—Methotrexate—urinary bladder cancer	0.000332	0.000809	CcSEcCtD
Cilazapril—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000332	0.000808	CcSEcCtD
Cilazapril—Asthenia—Cisplatin—urinary bladder cancer	0.000331	0.000806	CcSEcCtD
Cilazapril—Pharyngitis—Epirubicin—urinary bladder cancer	0.000331	0.000806	CcSEcCtD
Cilazapril—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000331	0.000806	CcSEcCtD
Cilazapril—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000329	0.000802	CcSEcCtD
Cilazapril—Urethral disorder—Epirubicin—urinary bladder cancer	0.000327	0.000796	CcSEcCtD
Cilazapril—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000325	0.000792	CcSEcCtD
Cilazapril—Epistaxis—Doxorubicin—urinary bladder cancer	0.000324	0.00079	CcSEcCtD
Cilazapril—Angiopathy—Methotrexate—urinary bladder cancer	0.000323	0.000787	CcSEcCtD
Cilazapril—Sinusitis—Doxorubicin—urinary bladder cancer	0.000322	0.000785	CcSEcCtD
Cilazapril—Immune system disorder—Methotrexate—urinary bladder cancer	0.000322	0.000784	CcSEcCtD
Cilazapril—Dizziness—Fluorouracil—urinary bladder cancer	0.000322	0.000784	CcSEcCtD
Cilazapril—Visual impairment—Epirubicin—urinary bladder cancer	0.000321	0.000783	CcSEcCtD
Cilazapril—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000321	0.000781	CcSEcCtD
Cilazapril—Chills—Methotrexate—urinary bladder cancer	0.00032	0.000779	CcSEcCtD
Cilazapril—Diarrhoea—Cisplatin—urinary bladder cancer	0.000316	0.000769	CcSEcCtD
Cilazapril—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000315	0.000768	CcSEcCtD
Cilazapril—Alopecia—Methotrexate—urinary bladder cancer	0.000315	0.000767	CcSEcCtD
Cilazapril—Vomiting—Gemcitabine—urinary bladder cancer	0.000315	0.000767	CcSEcCtD
Cilazapril—Bradycardia—Doxorubicin—urinary bladder cancer	0.000314	0.000765	CcSEcCtD
Cilazapril—Rash—Gemcitabine—urinary bladder cancer	0.000312	0.00076	CcSEcCtD
Cilazapril—Dermatitis—Gemcitabine—urinary bladder cancer	0.000312	0.000759	CcSEcCtD
Cilazapril—Hypersensitivity—Etoposide—urinary bladder cancer	0.000311	0.000758	CcSEcCtD
Cilazapril—Tinnitus—Epirubicin—urinary bladder cancer	0.000311	0.000757	CcSEcCtD
Cilazapril—Headache—Gemcitabine—urinary bladder cancer	0.00031	0.000755	CcSEcCtD
Cilazapril—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000309	0.000754	CcSEcCtD
Cilazapril—Flushing—Epirubicin—urinary bladder cancer	0.000309	0.000754	CcSEcCtD
Cilazapril—Vomiting—Fluorouracil—urinary bladder cancer	0.000309	0.000754	CcSEcCtD
Cilazapril—Rhinitis—Doxorubicin—urinary bladder cancer	0.000309	0.000753	CcSEcCtD
Cilazapril—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000307	0.000748	CcSEcCtD
Cilazapril—Rash—Fluorouracil—urinary bladder cancer	0.000307	0.000747	CcSEcCtD
Cilazapril—Dermatitis—Fluorouracil—urinary bladder cancer	0.000307	0.000747	CcSEcCtD
Cilazapril—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000306	0.000746	CcSEcCtD
Cilazapril—Headache—Fluorouracil—urinary bladder cancer	0.000305	0.000743	CcSEcCtD
Cilazapril—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000305	0.000742	CcSEcCtD
Cilazapril—Dysgeusia—Methotrexate—urinary bladder cancer	0.000304	0.00074	CcSEcCtD
Cilazapril—Asthenia—Etoposide—urinary bladder cancer	0.000303	0.000739	CcSEcCtD
Cilazapril—Angiopathy—Epirubicin—urinary bladder cancer	0.000303	0.000737	CcSEcCtD
Cilazapril—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000302	0.000737	CcSEcCtD
Cilazapril—Immune system disorder—Epirubicin—urinary bladder cancer	0.000301	0.000734	CcSEcCtD
Cilazapril—Chills—Epirubicin—urinary bladder cancer	0.000299	0.000729	CcSEcCtD
Cilazapril—Pruritus—Etoposide—urinary bladder cancer	0.000299	0.000728	CcSEcCtD
Cilazapril—Arrhythmia—Epirubicin—urinary bladder cancer	0.000298	0.000726	CcSEcCtD
Cilazapril—Visual impairment—Doxorubicin—urinary bladder cancer	0.000297	0.000724	CcSEcCtD
Cilazapril—Alopecia—Epirubicin—urinary bladder cancer	0.000295	0.000718	CcSEcCtD
Cilazapril—Nausea—Gemcitabine—urinary bladder cancer	0.000294	0.000716	CcSEcCtD
Cilazapril—Vomiting—Cisplatin—urinary bladder cancer	0.000293	0.000714	CcSEcCtD
Cilazapril—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000292	0.000711	CcSEcCtD
Cilazapril—Rash—Cisplatin—urinary bladder cancer	0.000291	0.000709	CcSEcCtD
Cilazapril—Dermatitis—Cisplatin—urinary bladder cancer	0.000291	0.000708	CcSEcCtD
Cilazapril—Diarrhoea—Etoposide—urinary bladder cancer	0.000289	0.000704	CcSEcCtD
Cilazapril—Nausea—Fluorouracil—urinary bladder cancer	0.000289	0.000704	CcSEcCtD
Cilazapril—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000288	0.000701	CcSEcCtD
Cilazapril—Tinnitus—Doxorubicin—urinary bladder cancer	0.000288	0.000701	CcSEcCtD
Cilazapril—Anaemia—Methotrexate—urinary bladder cancer	0.000287	0.000698	CcSEcCtD
Cilazapril—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000286	0.000698	CcSEcCtD
Cilazapril—Flushing—Doxorubicin—urinary bladder cancer	0.000286	0.000698	CcSEcCtD
Cilazapril—Flatulence—Epirubicin—urinary bladder cancer	0.000286	0.000697	CcSEcCtD
Cilazapril—Tension—Epirubicin—urinary bladder cancer	0.000285	0.000694	CcSEcCtD
Cilazapril—Dysgeusia—Epirubicin—urinary bladder cancer	0.000284	0.000692	CcSEcCtD
Cilazapril—Nervousness—Epirubicin—urinary bladder cancer	0.000282	0.000687	CcSEcCtD
Cilazapril—Angiopathy—Doxorubicin—urinary bladder cancer	0.00028	0.000682	CcSEcCtD
Cilazapril—Malaise—Methotrexate—urinary bladder cancer	0.00028	0.000681	CcSEcCtD
Cilazapril—Dizziness—Etoposide—urinary bladder cancer	0.000279	0.000681	CcSEcCtD
Cilazapril—Muscle spasms—Epirubicin—urinary bladder cancer	0.000279	0.00068	CcSEcCtD
Cilazapril—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000279	0.000679	CcSEcCtD
Cilazapril—Vertigo—Methotrexate—urinary bladder cancer	0.000279	0.000679	CcSEcCtD
Cilazapril—Leukopenia—Methotrexate—urinary bladder cancer	0.000278	0.000676	CcSEcCtD
Cilazapril—Chills—Doxorubicin—urinary bladder cancer	0.000277	0.000674	CcSEcCtD
Cilazapril—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000276	0.000671	CcSEcCtD
Cilazapril—Nausea—Cisplatin—urinary bladder cancer	0.000274	0.000667	CcSEcCtD
Cilazapril—Alopecia—Doxorubicin—urinary bladder cancer	0.000273	0.000664	CcSEcCtD
Cilazapril—Cough—Methotrexate—urinary bladder cancer	0.000271	0.000659	CcSEcCtD
Cilazapril—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000269	0.000656	CcSEcCtD
Cilazapril—Vomiting—Etoposide—urinary bladder cancer	0.000269	0.000655	CcSEcCtD
Cilazapril—Anaemia—Epirubicin—urinary bladder cancer	0.000268	0.000654	CcSEcCtD
Cilazapril—Rash—Etoposide—urinary bladder cancer	0.000266	0.000649	CcSEcCtD
Cilazapril—Dermatitis—Etoposide—urinary bladder cancer	0.000266	0.000649	CcSEcCtD
Cilazapril—Headache—Etoposide—urinary bladder cancer	0.000265	0.000645	CcSEcCtD
Cilazapril—Flatulence—Doxorubicin—urinary bladder cancer	0.000265	0.000645	CcSEcCtD
Cilazapril—Chest pain—Methotrexate—urinary bladder cancer	0.000264	0.000643	CcSEcCtD
Cilazapril—Arthralgia—Methotrexate—urinary bladder cancer	0.000264	0.000643	CcSEcCtD
Cilazapril—Myalgia—Methotrexate—urinary bladder cancer	0.000264	0.000643	CcSEcCtD
Cilazapril—Tension—Doxorubicin—urinary bladder cancer	0.000264	0.000642	CcSEcCtD
Cilazapril—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000263	0.000641	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000262	0.000639	CcSEcCtD
Cilazapril—Malaise—Epirubicin—urinary bladder cancer	0.000262	0.000638	CcSEcCtD
Cilazapril—Discomfort—Methotrexate—urinary bladder cancer	0.000261	0.000636	CcSEcCtD
Cilazapril—Nervousness—Doxorubicin—urinary bladder cancer	0.000261	0.000635	CcSEcCtD
Cilazapril—Vertigo—Epirubicin—urinary bladder cancer	0.000261	0.000635	CcSEcCtD
Cilazapril—Syncope—Epirubicin—urinary bladder cancer	0.00026	0.000634	CcSEcCtD
Cilazapril—Leukopenia—Epirubicin—urinary bladder cancer	0.00026	0.000633	CcSEcCtD
Cilazapril—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000258	0.000629	CcSEcCtD
Cilazapril—Palpitations—Epirubicin—urinary bladder cancer	0.000256	0.000625	CcSEcCtD
Cilazapril—Confusional state—Methotrexate—urinary bladder cancer	0.000255	0.000622	CcSEcCtD
Cilazapril—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000255	0.000621	CcSEcCtD
Cilazapril—Cough—Epirubicin—urinary bladder cancer	0.000253	0.000617	CcSEcCtD
Cilazapril—Nausea—Etoposide—urinary bladder cancer	0.000251	0.000612	CcSEcCtD
Cilazapril—Hypertension—Epirubicin—urinary bladder cancer	0.000251	0.00061	CcSEcCtD
Cilazapril—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000249	0.000607	CcSEcCtD
Cilazapril—Anaemia—Doxorubicin—urinary bladder cancer	0.000248	0.000605	CcSEcCtD
Cilazapril—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000248	0.000604	CcSEcCtD
Cilazapril—Arthralgia—Epirubicin—urinary bladder cancer	0.000247	0.000602	CcSEcCtD
Cilazapril—Chest pain—Epirubicin—urinary bladder cancer	0.000247	0.000602	CcSEcCtD
Cilazapril—Myalgia—Epirubicin—urinary bladder cancer	0.000247	0.000602	CcSEcCtD
Cilazapril—Anxiety—Epirubicin—urinary bladder cancer	0.000246	0.0006	CcSEcCtD
Cilazapril—Skin disorder—Methotrexate—urinary bladder cancer	0.000246	0.000599	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000245	0.000598	CcSEcCtD
Cilazapril—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000245	0.000596	CcSEcCtD
Cilazapril—Discomfort—Epirubicin—urinary bladder cancer	0.000244	0.000595	CcSEcCtD
Cilazapril—Malaise—Doxorubicin—urinary bladder cancer	0.000242	0.00059	CcSEcCtD
Cilazapril—Dry mouth—Epirubicin—urinary bladder cancer	0.000242	0.000589	CcSEcCtD
Cilazapril—Vertigo—Doxorubicin—urinary bladder cancer	0.000241	0.000588	CcSEcCtD
Cilazapril—Anorexia—Methotrexate—urinary bladder cancer	0.000241	0.000588	CcSEcCtD
Cilazapril—Syncope—Doxorubicin—urinary bladder cancer	0.000241	0.000587	CcSEcCtD
Cilazapril—Leukopenia—Doxorubicin—urinary bladder cancer	0.00024	0.000586	CcSEcCtD
Cilazapril—Confusional state—Epirubicin—urinary bladder cancer	0.000239	0.000582	CcSEcCtD
Cilazapril—Palpitations—Doxorubicin—urinary bladder cancer	0.000237	0.000578	CcSEcCtD
Cilazapril—Oedema—Epirubicin—urinary bladder cancer	0.000237	0.000577	CcSEcCtD
Cilazapril—Hypotension—Methotrexate—urinary bladder cancer	0.000237	0.000576	CcSEcCtD
Cilazapril—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000236	0.000575	CcSEcCtD
Cilazapril—Cough—Doxorubicin—urinary bladder cancer	0.000234	0.000571	CcSEcCtD
Cilazapril—Shock—Epirubicin—urinary bladder cancer	0.000233	0.000568	CcSEcCtD
Cilazapril—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000232	0.000565	CcSEcCtD
Cilazapril—Hypertension—Doxorubicin—urinary bladder cancer	0.000232	0.000565	CcSEcCtD
Cilazapril—Tachycardia—Epirubicin—urinary bladder cancer	0.000231	0.000563	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000231	0.000562	CcSEcCtD
Cilazapril—Skin disorder—Epirubicin—urinary bladder cancer	0.00023	0.000561	CcSEcCtD
Cilazapril—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000229	0.000558	CcSEcCtD
Cilazapril—Insomnia—Methotrexate—urinary bladder cancer	0.000229	0.000558	CcSEcCtD
Cilazapril—Chest pain—Doxorubicin—urinary bladder cancer	0.000229	0.000557	CcSEcCtD
Cilazapril—Arthralgia—Doxorubicin—urinary bladder cancer	0.000229	0.000557	CcSEcCtD
Cilazapril—Myalgia—Doxorubicin—urinary bladder cancer	0.000229	0.000557	CcSEcCtD
Cilazapril—Anxiety—Doxorubicin—urinary bladder cancer	0.000228	0.000555	CcSEcCtD
Cilazapril—Paraesthesia—Methotrexate—urinary bladder cancer	0.000227	0.000554	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000227	0.000553	CcSEcCtD
Cilazapril—Discomfort—Doxorubicin—urinary bladder cancer	0.000226	0.00055	CcSEcCtD
Cilazapril—Anorexia—Epirubicin—urinary bladder cancer	0.000226	0.00055	CcSEcCtD
Cilazapril—Dyspnoea—Methotrexate—urinary bladder cancer	0.000226	0.00055	CcSEcCtD
Cilazapril—Somnolence—Methotrexate—urinary bladder cancer	0.000225	0.000548	CcSEcCtD
Cilazapril—Dry mouth—Doxorubicin—urinary bladder cancer	0.000224	0.000545	CcSEcCtD
Cilazapril—Dyspepsia—Methotrexate—urinary bladder cancer	0.000223	0.000543	CcSEcCtD
Cilazapril—Hypotension—Epirubicin—urinary bladder cancer	0.000221	0.000539	CcSEcCtD
Cilazapril—Confusional state—Doxorubicin—urinary bladder cancer	0.000221	0.000538	CcSEcCtD
Cilazapril—Decreased appetite—Methotrexate—urinary bladder cancer	0.00022	0.000536	CcSEcCtD
Cilazapril—Oedema—Doxorubicin—urinary bladder cancer	0.000219	0.000534	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000219	0.000532	CcSEcCtD
Cilazapril—Fatigue—Methotrexate—urinary bladder cancer	0.000218	0.000532	CcSEcCtD
Cilazapril—Pain—Methotrexate—urinary bladder cancer	0.000216	0.000527	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000216	0.000526	CcSEcCtD
Cilazapril—Shock—Doxorubicin—urinary bladder cancer	0.000216	0.000525	CcSEcCtD
Cilazapril—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000215	0.000523	CcSEcCtD
Cilazapril—Insomnia—Epirubicin—urinary bladder cancer	0.000214	0.000522	CcSEcCtD
Cilazapril—Tachycardia—Doxorubicin—urinary bladder cancer	0.000214	0.000521	CcSEcCtD
Cilazapril—Skin disorder—Doxorubicin—urinary bladder cancer	0.000213	0.000519	CcSEcCtD
Cilazapril—Paraesthesia—Epirubicin—urinary bladder cancer	0.000213	0.000518	CcSEcCtD
Cilazapril—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000212	0.000516	CcSEcCtD
Cilazapril—Dyspnoea—Epirubicin—urinary bladder cancer	0.000211	0.000514	CcSEcCtD
Cilazapril—Somnolence—Epirubicin—urinary bladder cancer	0.000211	0.000513	CcSEcCtD
Cilazapril—Anorexia—Doxorubicin—urinary bladder cancer	0.000209	0.000509	CcSEcCtD
Cilazapril—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000209	0.000508	CcSEcCtD
Cilazapril—Dyspepsia—Epirubicin—urinary bladder cancer	0.000209	0.000508	CcSEcCtD
Cilazapril—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000207	0.000504	CcSEcCtD
Cilazapril—Decreased appetite—Epirubicin—urinary bladder cancer	0.000206	0.000502	CcSEcCtD
Cilazapril—Hypotension—Doxorubicin—urinary bladder cancer	0.000205	0.000499	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000205	0.000498	CcSEcCtD
Cilazapril—Fatigue—Epirubicin—urinary bladder cancer	0.000204	0.000498	CcSEcCtD
Cilazapril—Pain—Epirubicin—urinary bladder cancer	0.000203	0.000493	CcSEcCtD
Cilazapril—Constipation—Epirubicin—urinary bladder cancer	0.000203	0.000493	CcSEcCtD
Cilazapril—Urticaria—Methotrexate—urinary bladder cancer	0.000201	0.00049	CcSEcCtD
Cilazapril—Abdominal pain—Methotrexate—urinary bladder cancer	0.0002	0.000487	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.0002	0.000486	CcSEcCtD
Cilazapril—Insomnia—Doxorubicin—urinary bladder cancer	0.000198	0.000483	CcSEcCtD
Cilazapril—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000197	0.000479	CcSEcCtD
Cilazapril—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000195	0.000476	CcSEcCtD
Cilazapril—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000195	0.000476	CcSEcCtD
Cilazapril—Somnolence—Doxorubicin—urinary bladder cancer	0.000195	0.000475	CcSEcCtD
Cilazapril—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000194	0.000472	CcSEcCtD
Cilazapril—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000193	0.00047	CcSEcCtD
Cilazapril—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000191	0.000464	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000189	0.000461	CcSEcCtD
Cilazapril—Fatigue—Doxorubicin—urinary bladder cancer	0.000189	0.00046	CcSEcCtD
Cilazapril—Urticaria—Epirubicin—urinary bladder cancer	0.000188	0.000458	CcSEcCtD
Cilazapril—Pain—Doxorubicin—urinary bladder cancer	0.000187	0.000457	CcSEcCtD
Cilazapril—Constipation—Doxorubicin—urinary bladder cancer	0.000187	0.000457	CcSEcCtD
Cilazapril—Abdominal pain—Epirubicin—urinary bladder cancer	0.000187	0.000456	CcSEcCtD
Cilazapril—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000186	0.000454	CcSEcCtD
Cilazapril—Asthenia—Methotrexate—urinary bladder cancer	0.000182	0.000442	CcSEcCtD
Cilazapril—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000181	0.00044	CcSEcCtD
Cilazapril—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000179	0.000437	CcSEcCtD
Cilazapril—Pruritus—Methotrexate—urinary bladder cancer	0.000179	0.000436	CcSEcCtD
Cilazapril—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000175	0.000425	CcSEcCtD
Cilazapril—Urticaria—Doxorubicin—urinary bladder cancer	0.000174	0.000424	CcSEcCtD
Cilazapril—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000173	0.000422	CcSEcCtD
Cilazapril—Diarrhoea—Methotrexate—urinary bladder cancer	0.000173	0.000422	CcSEcCtD
Cilazapril—Asthenia—Epirubicin—urinary bladder cancer	0.00017	0.000414	CcSEcCtD
Cilazapril—Pruritus—Epirubicin—urinary bladder cancer	0.000168	0.000408	CcSEcCtD
Cilazapril—Dizziness—Methotrexate—urinary bladder cancer	0.000167	0.000408	CcSEcCtD
Cilazapril—Diarrhoea—Epirubicin—urinary bladder cancer	0.000162	0.000395	CcSEcCtD
Cilazapril—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000161	0.000393	CcSEcCtD
Cilazapril—Vomiting—Methotrexate—urinary bladder cancer	0.000161	0.000392	CcSEcCtD
Cilazapril—Rash—Methotrexate—urinary bladder cancer	0.00016	0.000389	CcSEcCtD
Cilazapril—Dermatitis—Methotrexate—urinary bladder cancer	0.000159	0.000388	CcSEcCtD
Cilazapril—Headache—Methotrexate—urinary bladder cancer	0.000159	0.000386	CcSEcCtD
Cilazapril—Asthenia—Doxorubicin—urinary bladder cancer	0.000157	0.000383	CcSEcCtD
Cilazapril—Dizziness—Epirubicin—urinary bladder cancer	0.000157	0.000382	CcSEcCtD
Cilazapril—Pruritus—Doxorubicin—urinary bladder cancer	0.000155	0.000378	CcSEcCtD
Cilazapril—Vomiting—Epirubicin—urinary bladder cancer	0.000151	0.000367	CcSEcCtD
Cilazapril—Nausea—Methotrexate—urinary bladder cancer	0.00015	0.000366	CcSEcCtD
Cilazapril—Diarrhoea—Doxorubicin—urinary bladder cancer	0.00015	0.000365	CcSEcCtD
Cilazapril—Rash—Epirubicin—urinary bladder cancer	0.000149	0.000364	CcSEcCtD
Cilazapril—Dermatitis—Epirubicin—urinary bladder cancer	0.000149	0.000364	CcSEcCtD
Cilazapril—Headache—Epirubicin—urinary bladder cancer	0.000148	0.000362	CcSEcCtD
Cilazapril—Dizziness—Doxorubicin—urinary bladder cancer	0.000145	0.000353	CcSEcCtD
Cilazapril—Nausea—Epirubicin—urinary bladder cancer	0.000141	0.000343	CcSEcCtD
Cilazapril—Vomiting—Doxorubicin—urinary bladder cancer	0.000139	0.00034	CcSEcCtD
Cilazapril—Rash—Doxorubicin—urinary bladder cancer	0.000138	0.000337	CcSEcCtD
Cilazapril—Dermatitis—Doxorubicin—urinary bladder cancer	0.000138	0.000336	CcSEcCtD
Cilazapril—Headache—Doxorubicin—urinary bladder cancer	0.000137	0.000335	CcSEcCtD
Cilazapril—Nausea—Doxorubicin—urinary bladder cancer	0.00013	0.000317	CcSEcCtD
